What if we could stop Alzheimer's disease before the first symptom ever appears? In this groundbreaking episode, we sit down with Dr. Mike Malek-Ahmadi, a researcher, to explore the cutting-edge frontier of pre-symptomatic Alzheimer's intervention.
Dr. Malek-Ahmadi takes us deep into the science of early detection, explaining how researchers are now identifying biomarkers and brain changes decades before memory loss begins. We discuss the revolutionary clinical trials targeting at-risk individuals, the ethical complexities of treating people who feel perfectly healthy, and the potential to fundamentally transform how we approach neurodegenerative disease.
From amyloid plaques to tau proteins, from genetic risk factors to lifestyle modifications, this conversation challenges everything we thought we knew about Alzheimer's treatment. Dr. Malek-Ahmadi shares insights from the latest research, the promise of disease-modifying therapies, and what this paradigm shift means for patients, families, and the future of brain health.